Epigenetic Treatment of Neuropsychiatric Disorders: Autism and Schizophrenia

Walter H Moos1,2, Eleni Maneta3,4, Carl A Pinkert5,6

  • 1Department of Pharmaceutical Chemistry, School of Pharmacy, University of California San Francisco, San Francisco, CA, USA.

Drug Development Research
|February 23, 2016
PubMed

Insights

Novel carnitine esters show promise for treating neuropsychiatric disorders by targeting mitochondrial dysfunction and epigenetic pathways. These compounds may offer a new therapeutic avenue by protecting neurons and improving synaptic plasticity.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Neuropsychiatric disorders share mitochondrial dysfunction and common biological pathways.
  • Current treatments are largely interventional and do not address core disease symptoms.
  • Molecular-targeted therapies have shown limited success.

Purpose of the Study:

  • To review emerging epigenetic-driven therapeutic approaches for neuropsychiatric disorders.
  • To explore the potential of novel acylcarnitine esters (carnitinoids) as a treatment strategy.
  • To outline the neuroprotective effects of carnitinoids in conditions like autism spectrum disorder and schizophrenia.

Main Methods:

  • Review of current literature on epigenetic modifications and mitochondrial function in neuropsychiatric disorders.
  • Analysis of the mechanism of action of carnitinoids as biomimetic coenzyme A surrogates.
  • Discussion of carnitinoid transport, localization, and effects on gene regulation and neuronal health.

Main Results:

  • Carnitinoids act on master regulators of antioxidant and cytoprotective genes.
  • These compounds inhibit histone deacetylase, potentially reinvigorating synaptic plasticity.
  • Carnitinoids demonstrate potential for protecting against neuronal damage.

Conclusions:

  • Epigenetic-driven approaches using carnitinoids represent a promising therapeutic strategy for neuropsychiatric disorders.
  • Carnitinoids may address core symptoms by targeting underlying mitochondrial dysfunction.
  • Further research into carnitinoids could lead to novel treatments for autism spectrum disorder and schizophrenia.

Related Concept Videos

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders01:27

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.4K
Biological Causes of Schizophrenia01:29

Biological Causes of Schizophrenia

Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
1.0K
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
1.7K
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
662
Modeling in Therapy01:26

Modeling in Therapy

Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in...
680
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
1.9K